Biotech · Private company
Pathos AI, Inc.
Track this companyFree. Adds Pathos AI, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- PocenbrodibPhase 2 · mCRPC (Metastatic Castration-resistant Prostate Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
- Pocenbrodib and DarolutamidePhase 2 · mCRPC (Metastatic Castration-resistant Prostate Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPCPHASE1_PHASE2 · RECRUITING · started Feb 7, 2025ClinicalTrials.gov NCT06785636 · fetched Nov 12, 2026